Real-time enrollment status for this recurrent diffuse large b-cell lymphoma activated b-cell type clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:54 PM UTC
| NCT Number | NCT05755087 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Lapo Alinari |
| Last Updated on CT.gov | February 27, 2026 (Feb 27, 2026) |
As of July 17, 2026: Clinical trial NCT05755087 is currently recruiting participants. This phase1 study for recurrent diffuse large b-cell lymphoma activated b-cell type is actively seeking new participants at 1 location across the United States. The study is sponsored by Lapo Alinari. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05755087 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05755087 was last updated Feb 27, 2026 (February 27, 2026). HelloStudys verifies this status automatically.